Related Experiment Video

Updated: May 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients

Sophie Liabeuf1, Aurélie Lenglet, Lucie Desjardins

  • 1INSERM U-1088, Amiens, France.

Kidney International
|August 17, 2012
PubMed

Insights

Beta-2 microglobulin (B2M) levels increase with chronic kidney disease (CKD) progression. Higher B2M independently predicts mortality and cardiovascular events in CKD patients, outperforming other markers.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biomarker Research

Background:

  • Beta-2 microglobulin (B2M) is a known marker in dialysis patients for uremic toxins and amyloidosis.
  • The role of B2M in patients with chronic kidney disease (CKD) not yet on dialysis remains unclear.
  • Understanding B2M's impact across CKD stages is crucial for risk stratification.

Purpose of the Study:

  • To investigate the relationship between plasma B2M levels and clinical outcomes in patients with varying stages of CKD.
  • To assess B2M's association with cardiovascular events and mortality in both predialysis and dialysis populations.
  • To compare B2M's predictive power against established risk factors like eGFR and inflammation markers.

Main Methods:

  • Prospective study of 142 patients with different stages of CKD (mean age 67 years).
  • Measurement of baseline plasma B2M levels, vascular calcification, arterial stiffness, and bone density.
  • Follow-up for clinical outcomes including mortality and cardiovascular events over a mean period of 969 days.

Main Results:

  • Plasma B2M levels increased progressively with CKD stage, being highest in hemodialysis patients.
  • Higher baseline B2M levels were associated with vascular calcification.
  • Elevated B2M independently predicted overall mortality, cardiovascular mortality, and cardiovascular events across the CKD cohort, and cardiovascular events in the predialysis subgroup. B2M outperformed eGFR and other factors in predictive ability.

Conclusions:

  • Plasma B2M is a strong predictor of adverse outcomes, including mortality and cardiovascular events, in patients across all stages of CKD.
  • B2M levels correlate with CKD progression and vascular calcification.
  • B2M demonstrates superior predictive value compared to traditional risk factors, highlighting its potential clinical utility in managing CKD patients.

More Related Videos

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery05:30

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Published on: January 31, 2025

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...